NewLab BioQuality GmbH is now a part of Charles River, a global contract research organization with offerings that span the entire drug development process, from discovery through market approval.
Charles River Biopharmaceutical Services provides manufacturing and testing services to support the development and commercialization of biologics. Through the acquisition of NewLab, we expanded our portfolio and global footprint to provide you with even more services, flexibility, experience and expertise in multiple regulatory environments. Our geographic scope now includes Erkrath and Cologne, Germany, which complement our existing facilities in Malvern, PA, USA; Edinburgh, UK; and Ballina, Co. Mayo, Ireland.
We are pleased to announce that we have recently updated and expanded our Cologne, Germany-based viral clearance facility. Click here to view a tour of our new viral clearance facility.
early-stage biopharmaceutical manufacturing services
For more information, contact us at askcharlesriver@crl.com.